Sigachi Industries Limited (NSE:SIGACHI)
34.56
-1.47 (-4.08%)
Aug 6, 2025, 3:29 PM IST
ShockWave Medical Revenue
Sigachi Industries had revenue of 1.28B INR in the quarter ending June 30, 2025, with 33.99% growth. This brings the company's revenue in the last twelve months to 5.21B, up 27.03% year-over-year. In the fiscal year ending March 31, 2025, Sigachi Industries had annual revenue of 4.88B with 20.82% growth.
Revenue (ttm)
5.21B
Revenue Growth
+27.03%
P/S Ratio
2.54
Revenue / Employee
5.26M
Employees
991
Market Cap
13.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 4.88B | 841.32M | 20.82% |
Mar 31, 2024 | 4.04B | 1.02B | 33.79% |
Mar 31, 2023 | 3.02B | 517.55M | 20.68% |
Mar 31, 2022 | 2.50B | 544.85M | 27.83% |
Mar 31, 2021 | 1.96B | 530.96M | 37.21% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 93.60B |
Cipla | 274.80B |
Mankind Pharma | 129.10B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Fortis Healthcare | 77.86B |
Aurobindo Pharma | 317.24B |